Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
Recruiting now · Early Phase 1
Conditions studied: Voice Disorders, Vocal Fold Polyp, Vocal Nodules in Adults, Muscle Tension Dysphonia
In brief
Vocal hyperfunction (VH) is the most commonly treated class of voice disorders by speech-language pathologists and voice therapy is the primary curative treatment. Patients and clinicians report that generalizing improved voicing into daily life is the most significant barrier to successful therapy. We will test if extending biofeedback into the patient's daily life using ambulatory voice monitoring will significantly improve generalization during therapy and if individual patient factors, like how easily they can modify their voice and engagement during therapy, moderate the effects of the biofeedback.
Key facts
- Study ID
- NCT05970562
- Run by
- Massachusetts General Hospital
- People needed
- 100
- Starts
- 2024-03-01
- Expected to finish
- 2029-04-01
- Last updated by the study team
- 2026-07-16
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
- Boston Medical Center — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.